Mediolanum International Funds Ltd Purchases 1,696 Shares of Mettler-Toledo International Inc. (NYSE:MTD)

Mediolanum International Funds Ltd boosted its holdings in shares of Mettler-Toledo International Inc. (NYSE:MTD) by 47.0% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 5,307 shares of the medical instruments supplier’s stock after acquiring an additional 1,696 shares during the quarter. Mediolanum International Funds Ltd’s holdings in Mettler-Toledo International were worth $6,458,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently added to or reduced their stakes in the business. Creative Planning raised its holdings in shares of Mettler-Toledo International by 12.8% during the 2nd quarter. Creative Planning now owns 2,698 shares of the medical instruments supplier’s stock valued at $3,771,000 after purchasing an additional 306 shares in the last quarter. Sanctuary Advisors LLC bought a new position in Mettler-Toledo International during the second quarter valued at about $500,000. Czech National Bank lifted its position in shares of Mettler-Toledo International by 6.2% in the third quarter. Czech National Bank now owns 4,322 shares of the medical instruments supplier’s stock worth $6,482,000 after buying an additional 252 shares during the last quarter. Park Avenue Securities LLC boosted its stake in shares of Mettler-Toledo International by 13.7% during the 3rd quarter. Park Avenue Securities LLC now owns 299 shares of the medical instruments supplier’s stock worth $448,000 after acquiring an additional 36 shares in the last quarter. Finally, Quent Capital LLC increased its holdings in shares of Mettler-Toledo International by 6.5% during the 3rd quarter. Quent Capital LLC now owns 245 shares of the medical instruments supplier’s stock valued at $367,000 after acquiring an additional 15 shares during the last quarter. 95.07% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling

In other news, insider Gerry Keller sold 140 shares of the company’s stock in a transaction dated Tuesday, December 3rd. The shares were sold at an average price of $1,254.09, for a total value of $175,572.60. Following the sale, the insider now owns 6 shares of the company’s stock, valued at approximately $7,524.54. This represents a 95.89 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Elisha W. Finney sold 76 shares of Mettler-Toledo International stock in a transaction dated Monday, November 11th. The shares were sold at an average price of $1,311.75, for a total transaction of $99,693.00. Following the transaction, the director now directly owns 240 shares of the company’s stock, valued at $314,820. This represents a 24.05 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Company insiders own 1.94% of the company’s stock.

Analyst Upgrades and Downgrades

MTD has been the subject of several analyst reports. Citigroup upgraded Mettler-Toledo International from a “sell” rating to a “neutral” rating and boosted their target price for the stock from $1,200.00 to $1,300.00 in a report on Wednesday, December 11th. Stifel Nicolaus decreased their price objective on shares of Mettler-Toledo International from $1,550.00 to $1,450.00 and set a “buy” rating for the company in a report on Monday, November 11th. Robert W. Baird dropped their target price on shares of Mettler-Toledo International from $1,375.00 to $1,310.00 and set a “neutral” rating on the stock in a report on Monday, November 11th. Wolfe Research started coverage on shares of Mettler-Toledo International in a report on Friday, December 13th. They set a “peer perform” rating for the company. Finally, Wells Fargo & Company cut their price objective on Mettler-Toledo International from $1,400.00 to $1,350.00 and set an “equal weight” rating for the company in a research report on Monday, November 11th. One research analyst has rated the stock with a sell rating, six have assigned a hold rating and three have issued a buy rating to the company. According to MarketBeat, the company presently has an average rating of “Hold” and an average target price of $1,351.25.

Mettler-Toledo International Trading Up 0.1 %

Shares of MTD stock opened at $1,365.36 on Friday. The company has a market capitalization of $28.81 billion, a P/E ratio of 36.81, a P/E/G ratio of 4.72 and a beta of 1.12. Mettler-Toledo International Inc. has a 12 month low of $1,133.46 and a 12 month high of $1,546.93. The stock has a 50 day moving average of $1,264.05 and a two-hundred day moving average of $1,343.61.

Mettler-Toledo International (NYSE:MTD) last announced its quarterly earnings results on Thursday, November 7th. The medical instruments supplier reported $10.21 earnings per share (EPS) for the quarter, beating the consensus estimate of $10.00 by $0.21. The firm had revenue of $954.54 million for the quarter, compared to analyst estimates of $941.93 million. Mettler-Toledo International had a net margin of 21.15% and a negative return on equity of 531.78%. Sell-side analysts predict that Mettler-Toledo International Inc. will post 40.42 earnings per share for the current fiscal year.

Mettler-Toledo International Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.